Retension Pharmaceuticals, Inc. RTSN
Annual
Quarterly
No annual revenue total was found in Retension Pharmaceuticals, Inc.'s SEC filings.
Retension Pharmaceuticals, Inc. (RTSN) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
—
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RTSN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Mclean, VA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2002988
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 23, 2026 | Oct 21, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 13, 2026 | Oct 9, 2026 |
All 45 Retension Pharmaceuticals, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.